Comparing suitable naïve versus pre-treated DME patients

Video

Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.


Javier Zarranz-Ventura MD, PhD, FEBO, a vitreoretinal consultant at
Institut Clínic de Oftalmologia (ICOF), Hospital Clínic de Barcelona andInstitut de Investigacions Biomediques August Pi i Sunyer (IDIBAPS), discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.

See more EURETINA coverage

Related Videos
© 2024 MJH Life Sciences

All rights reserved.